Replies to post #256159 on Biotech Values

[Doc328]

They do have a program to develop drugs for multidrug resistant pathogens and had funded an initiative for multi-resistant TB many years ago. Not sure if this has any connection to hiring Peter Marks

https://investor.lilly.com/news-releases/news-release-details/lilly-collaborates-openai-discover-novel-medicines-treat-drug